Agios Pharma (AGIO) Tops Q3 EPS by 3c; Reports Cash and Cash Equivalents of $1.4B

Agios Pharma (NASDAQ: AGIO) reported Q3 EPS of ($1.56), $0.03 better than the analyst estimate of ($1.59).

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
• JPMorgan Downgrades JD Logistics Inc (2618:HK) (JDLGF) to Neutral